Ectopic fat and cardiovascular disease: What is the link?

被引:150
作者
Gastaldelli, A. [1 ]
Basta, G. [1 ]
机构
[1] CNR, Inst Clin Physiol, Natl Res Council, Cardiometab Risk Unit, I-56100 Pisa, Italy
关键词
Visceral fat; Cardiovascular disease; NAFLD - non-alcoholic fatty liver disease; Epicardial fat; GLYCATION END-PRODUCTS; EPICARDIAL ADIPOSE-TISSUE; CIRCULATING SOLUBLE RECEPTOR; HEPATIC INSULIN-RESISTANCE; TYPE-2; DIABETES-MELLITUS; CORONARY-HEART-DISEASE; BODY-MASS INDEX; METABOLIC SYNDROME; LIVER-DISEASE; TRIGLYCERIDE CONTENT;
D O I
10.1016/j.numecd.2010.05.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aim: of this paper is to review the recent literature on the relationship between ectopic fat accumulation and cardiovascular disease. Data synthesis: Ectopic fat is an important predictor of metabolic (in particular insulin resistance) and cardiovascular disease, carrying more risk than general fat accumulation. Recent studies have shown a link between ectopic fat accumulation, as cardiac (epicardial or intra-myocardial fat) and/or visceral and/or hepatic fat, and development of atherosclerosis, coronary heart disease and hypertension. Conclusions: Ectopic fat accumulation is not only a marker of cardiometabolic disease, since through the release of adipocitokines, lipotoxic and glucotoxic agents, participates in the crosstalk with insulin-sensitive organs leading to metabolic, cardiac and vascular dysfunctions. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:481 / 490
页数:10
相关论文
共 104 条
[1]
Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men [J].
Abate, N ;
Chandalia, M ;
Snell, PG ;
Grundy, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2750-2755
[2]
Genetic basis of lipodystrophies and management of metabolic complications [J].
Agarwal, AK ;
Garg, A .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :297-311
[3]
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[4]
AYGUN C, 2007, DIG DIS SCI
[5]
At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products [J].
Basta, G ;
Lazzerini, G ;
Del Turco, S ;
Ratto, GM ;
Schmidt, AM ;
De Caterina, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) :1401-1407
[6]
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[7]
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications [J].
Basta, Giuseppina .
ATHEROSCLEROSIS, 2008, 196 (01) :9-21
[8]
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein [J].
Basta, Giuseppina ;
Sironi, Anna Maria ;
Lazzerini, Guido ;
Del Turco, Serena ;
Buzzigoli, Emma ;
Casolaro, Arturo ;
Natali, Andrea ;
Ferrannini, Ele ;
Gastaldelli, Amalia .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4628-4634
[9]
Glycoxidation and lipoxidation in atherogenesis [J].
Baynes, JW ;
Thorpe, SR .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1708-1716
[10]
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478